QGEN
QGEN
NYSE · Life Sciences Tools & Services

Qiagen N.V.

$43.71
+0.02 (+0.05%)
As of Sep 23, 9:48 PM ET ·
Financial Highlights (FY 2026)
Revenue
2.02B
Net Income
410.40M
Gross Margin
63.7%
Profit Margin
20.3%
Rev Growth
-0.8%
D/E Ratio
0.44
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 63.7% 63.7% 30.4% 30.4%
Operating Margin 22.2% 20.0% 6.7% 6.5%
Profit Margin 20.3% 19.3% 4.1% 4.8%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 2.02B 2.04B 2.80B 2.83B
Gross Profit 1.29B 1.30B 851.01M 860.99M
Operating Income 447.57M 406.10M 188.75M 184.86M
Net Income 410.40M 372.38M 113.25M 136.27M
Gross Margin 63.7% 63.7% 30.4% 30.4%
Operating Margin 22.2% 20.0% 6.7% 6.5%
Profit Margin 20.3% 19.3% 4.1% 4.8%
Rev Growth -0.8% -0.8% +10.7% +5.3%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 1.39B 1.39B 2.25B 2.65B
Total Equity 3.18B 3.18B 7.69B 7.73B
D/E Ratio 0.44 0.44 0.29 0.34
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 455.30M 436.06M 241.59M 268.48M
Free Cash Flow 174.05M 184.00M